Strict sodium intake — with or without restrictions on fluid intake — is unlikely to confer clinical benefits on patients with heart failure, reported investigators. Their...
Over the past 30 years, chronic kidney disease has become one of the leading causes of death and years of healthy life lost in Latin America....
Latin America is the region with the highest burden of chronic kidney disease (CKD), in terms of disability-adjusted life years and premature deaths. This situation partly...
TOPLINE: Researchers found a significant association between chronic kidney disease (CKD) and increased tooth loss in postmenopausal women, particularly those aged 66-79 years. METHODOLOGY: The study...
Safety Measures Clazakizumab was well tolerated, with the most common serious adverse events being serious infection (12.5% in the low-dose group, 9.4% in the medium-dose group,...
STOCKHOLM — In the treatment of type 2 diabetes, sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1 RAs) show independent benefits that...
This transcript has been edited for clarity. Tricia Ward: Hi. I’m Tricia Ward, from theheart.org | Medscape Cardiology. I’m joined today by Dr Matthew Budoff. He is...
LYON, FRANCE — High levels of lipoprotein(a) [Lp(a)] in the blood are associated with a significantly increased risk for chronic kidney disease, report investigators who are...
The use of semaglutide for non-diabetic obese patients with cardiovascular disease was first reported to be associated with significant benefit in the SELECT trial, where major...